발행물
컨퍼런스
난치질환 개선을 위한 기초연구 심포지엄
,
Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1
2021년 국립암센터 면역세포치료사업단 계속과제 중간발표 심포지움
면역세포 표면 엔지니어링을 통해 생성된 항암 면역 엑소좀 개발
ISEV 2022
Temsirolimus enhances anti-cancer immunity by inhibiting the secretion of small extracellular vesicles containing PD-L?
Reprogrammed T cell exosomes by surface engineering of cytokine induce potent anti-tumor effects
Macitentan attenuate extracellular vesicle PD-L? mediated immunosuppression